Regeneration of injured central nervous system axons

Details Regeneration of injured central nervous system axons Regeneration of injured central nervous system axons

1995-01-17

1996-12-03

Smith, Lynette F.

Drug, bio-affecting and body treating compositions

Lymphokine

424 852, 424 855, 607 89, A61N 700, A61K 4505, A61K 3821

Patent

active

055805558

ABSTRACT:
Administration of tumor necrosis factor to the site of injured central nervous system axons will result in facilitation of the regeneration of axons across the site of the injury. Recombinant human tumor necrosis factor is the preferred substance for such use.

REFERENCES:
patent: 4525340 (1985-06-01), Lange et al.
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4879111 (1989-11-01), Chong
patent: 4966144 (1990-10-01), Rochkind et al.
Assia, E. et al "Temporal parameters of low energy laser irradiation for optimal delay of post-traumatic degeneration of rat optic nerve", Brain Research, 476 (1989), 205-212.
Hadani, et al. PNAS, USA 81:7965-7969, 1984.
Schwartz, et al., Science 228:600-603, 1985.
Robbins, et al. J. Immunol. 139(8):2593-2597, 1987.
Selmaj et al., Annals Neurology 23(4):339-346, 1988.
Assia, et al, 1989, "Temporal parameters of low energy . . . " Brain Research 476:205-212.

Affiliated with

Also associated with

Rating

Regeneration of injured central nervous system axons does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Regeneration of injured central nervous system axons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regeneration of injured central nervous system axons will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-783266